Camlin Fine Sciences Limited (BOM:532834)

Market Cap	27.55B
Revenue (ttm)	17.52B
Net Income (ttm)	-292.05M
Shares Out	192.09M
EPS (ttm)	-1.61
PE Ratio	139.87
Forward PE	33.54
Dividend	n/a
Ex-Dividend Date	n/a

Volume	27,197
Average Volume	36,528
Open	142.10
Previous Close	142.05
Day's Range	135.05 - 143.05
52-Week Range	113.40 - 334.70
Beta	0.23
RSI	45.76
Earnings Date	Feb 2, 2026

About Camlin Fine Sciences

Camlin Fine Sciences Limited, together with its subsidiaries, research, develops, manufactures, and markets specialty chemicals, ingredients, and additive blend products in India and internationally. The company offers shelf-life solutions, which include basic ingredients, such as tert-butylhydroquinone (TBHQ), Butylated Hydroxyanisole (BHA), Butylated Hydroxytoluene (BHT), and Ascorbyl Palmitate (ASP); aroma ingredients, including vanillin and ethyl vanillin, natural vanillin, and some of its combinations; performance chemicals that include Hy...

• Industry: Chemicals and Allied Products
• Founded: 1931
• Employees: 661
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 532834

Financial Performance

In 2024, Camlin Fine Sciences's revenue was 16.67 billion, an increase of 14.62% compared to the previous year's 14.54 billion. Losses were -1.39 billion, 49.9% more than in 2023.